All industries
2087
results for
All industries
Filters
Refine your search
Malt extract designed for pharmaceutical preparations. It is an excipient and can be used for pet-food applications. Shelf life: 5 years. Benefits:
- Vegetal proteins, soluble in water
- Gives a clear solution
- Nanoparticles and GMO-free
- TSE/BSE contamination free
TDS
Protease designed for pharmaceutical preparations. It is
suitable for in-vitro cell testing and parasite detection. Shelf life: 30
months. Benefits:
- Nanoparticles and GMO-free
- Shows activity in acid environments between 37°C and 42°C
- Proteolytic Activity 1:10000 NF/USP = 2000-2200 U/g FIP
- TSE/BSE…
TDS
Peptone designed for pharmaceutical applications. It is a desiccated
liver powder from Italian pork liver. Shelf life: 3 years. Benefits:
- Mask unpleasant taste
- Improves palatability of the final product
- Nanoparticles and GMO-free
- TSE/BSE contamination free
TDS
Peptone designed for pharmaceutical preparations. It is a liver
powder from chicken liver. Shelf life: 3 years. Benefits:
- Mask unpleasant taste
- Improves palatability of the final product
- Nanoparticles and GMO-free
- TSE/BSE contamination free
TDS
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
- It maintains low level of endotoxins with the bioburden limits- BET/MLT
- Controlled metallic impurities
- Developed for…
TDS
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Bulking agent and antioxidant specially developed for solid and semi-solid dosage forms.Benefits:
- pH adjustment
- Clear and colorless or not more intensely colored than reference solution Y7, BY7 or GY7
TDS
Preservative specially developed for injectable formulations, solid and semi-solid dosage forms.Benefits:
- DMF Filed
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Excipient for use in pharmaceutical applications.Benefits:
- Acts as a preservative
TDS
Excipient for pharmaceutical applications.Benefits:
- Effloresces in warm, dry air. Its solutions are alkaline to phenolphthalein TS, a 0.1 M solution having a pH of about 9
- Freely soluble in water, very slightly soluble in alcohol
TDS
Excipient recommended for pharmaceutical applications.
TDS
Coating agent developed for solid and semi-solid dosage forms.Benefits:
- Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
TDS
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20190000639
TDS